Nordson (NDSN) Releases Quarterly Earnings, Misses Expectations By $0.06 EPS

Nordson (NASDAQ: NDSN) issued its quarterly earnings data on Thursday. The company reported $0.62 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.68 by $0.06. The company had revenue of $347.04 million for the quarter, compared to the consensus estimate of $348.93 million. During the same quarter in the prior year, the company posted $0.62 earnings per share. The company’s quarterly revenue was up 25.8% on a year-over-year basis. Nordson updated its Q2 guidance to $0.78-0.87 EPS.

A number of research firms have also recently commented on NDSN. Analysts at Wellington Shields initiated coverage on shares of Nordson in a research note to investors on Tuesday, February 5th. They set an “accumulate” rating on the stock. Analysts at Oppenheimer reiterated an “outperform” rating on shares of Nordson in a research note to investors on Monday, December 17th. They now have a $70.00 price target on the stock.

Three analysts have rated the stock with a buy rating, one has issued an overweight rating, and six have given a hold rating to the stock. The stock presently has an average rating of “overweight” and a consensus price target of $71.57.

Nordson (NDSN) traded down 2.75% on Thursday, hitting $66.86. Nordson (NDSN) has a 52-week low of $47.82 and a 52-week high of $70.84. The stock’s 50-day moving average is currently $67.25. The company has a market cap of $4.301 billion and a price-to-earnings ratio of 19.93.

The company also recently declared a quarterly dividend, which is scheduled for Tuesday, March 12th. Stockholders of record on Tuesday, February 26th will be given a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a yield of 0.90%. The ex-dividend date of this dividend is Friday, February 22nd.

Nordson Corporation is engaged in manufacturing of equipment used for precision material dispensing, testing and inspection, surface preparation and curing.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.

Latest News

Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Supreme Court Allows Regulators to Challenge Generic Drug Agreements
Car Sales in Europe Hit Record Lows
Car Sales in Europe Hit Record Lows
Woman once on Death Row to Go Free
Woman once on Death Row to Go Free
Bidding for Back Bay Parking Spaces Reaches $560,000
Bidding for Back Bay Parking Spaces Reaches $560,000
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Vermont Grappling with Nation’s Second Highest Rate of Lyme disease
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat
Concerns about Origins of Genetically Modified Wheat Affect US White Wheat


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe